On December 15th, a delegation of five people, including Yi Yueneng, Chairman of Hunan Yineng Biopharmaceutical Co., Ltd., and Shi Yuansheng, CEO, visited our company for inspection and exchange. Shen Fanshun, General Manager of our company, Liu Yan, Deputy General Manager, Kang Yongfeng, Deputy General Manager, and Ouyang Xiye, Dean of the Drug Research Institute, engaged in discussions with Yineng Biopharmaceutical on deepening cooperation between the two parties.

Yi Yueneng and his delegation visited the company's exhibition hall and the intelligent production line for traditional Chinese medicine extraction. Subsequently, the two parties held a discussion on matters such as cooperation in new drug research and development, technical services, and more.

Yi Yue fully affirmed the company's development and intelligent production line, proposing that in-depth technical cooperation with the company can be achieved through MAH methods, technology transfer, and other means, to realize "scientific and technological cooperation and win-win results in production and research". Shen Fanshun, the general manager of the company, affirmed the cooperation projects that have been completed by both parties and clarified the direction for further cooperation. Both parties reached a strategic cooperation agreement in areas such as the research of classic famous formulas and other new drugs, the standard research of ultra-fine herbal pieces, the improved research of the company's characteristic patented drugs, the research on upgrading pharmacopoeia standards for the company's ministerial standard products, and the technology transfer of characteristic preparation products.